Market Size of France Diabetes Devices Industry
| Study Period | 2018 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 1.30 Billion |
| Market Size (2029) | USD 1.79 Billion |
| CAGR (2024 - 2029) | 6.58 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
France Diabetes Devices Market Analysis
The France Diabetes Devices Market size is estimated at USD 1.30 billion in 2024, and is expected to reach USD 1.79 billion by 2029, growing at a CAGR of 6.58% during the forecast period (2024-2029).
In France, the prevalence of treated diabetes has been estimated at 4.6%, or more than 3 million people, and 5.2% in Northern France. The healthcare need for the treatment and management of diabetes is the main focus of the diabetes market. In France, the diabetes market is divided into self-monitoring of blood glucose (SBMG), continuous glucose monitoring (CGM), and insulin pumps. A survey conducted by the EU Commission revealed that one in 10 people in France has diabetes.
However, France does not have the highest diabetes prevalence rate in Europe. In 2022, Germany had the highest percentage of adults living with diabetes at 15.4%. Portugal followed with the second-highest rate at 14.6%. On the other hand, Ireland had the lowest diabetes rate in Europe at 4.5%. Still, nearly a million people are diagnosed with diabetes in France, according to the World Health Organization (WHO). And diabetes has the highest prevalence among all chronic conditions in France.
Diabetes has the highest prevalence among all chronic conditions covered 100% by France's statutory health insurance (SHI), and the number of covered patients has doubled in the past 10 years. France is one of the major countries in the Europe region.
According to the World Health Organization (WHO), about a million are diagnosed with diabetes in France. The prevalence of diabetes is growing among all ages in France, which can be attributed to the growing obese population, along with unhealthy diets and sedentary lifestyles of people.
Furthermore, approximately 0.26 million are estimated to live with Type 1 diabetes in the region. Thus, the rising prevalence of diabetes and obesity, growing awareness, regarding diabetic care, healthcare expenditure, and technological advancements are a few factors that are further driving the market for diabetes care devices in France.
In France, there is a centralized health care system their all the reimbursement decisions are taken at a national level and then applies to all of the countries. For diabetes technological devices in France, the reimbursement is based on the tariff system.
France Diabetes Devices Industry Segmentation
More user-friendly and unobtrusive devices are available, from improved insulin pumps to continuous glucose monitors (CGM) and blood glucose meters. The France diabetes device market comprises component management devices and monitoring devices. The report offers the value (in USD) and volume (in units) for the above segments.
| Monitoring Devices | |||||
| |||||
|
| Management Devices | |||||
| |||||
| Insulin Syringes | |||||
| Insulin Cartridges | |||||
| Disposable Pens |
France Diabetes Devices Market Size Summary
The France diabetes device market is poised for significant growth, driven by the increasing prevalence of diabetes and the rising demand for effective management solutions. The market is segmented into self-monitoring of blood glucose, continuous glucose monitoring, and insulin pumps, catering to the diverse needs of the diabetic population. Despite not having the highest diabetes prevalence in Europe, France faces a substantial healthcare challenge, with a significant portion of its population affected by the condition. The French healthcare system, with its centralized approach and statutory health insurance coverage, plays a crucial role in facilitating access to diabetes care devices. Technological advancements and growing awareness about diabetic care are further propelling the market, as innovations like the Dexcom G6 RT-CGM system offer cost-effective solutions for long-term diabetes management.
The market landscape is characterized by strategic partnerships and acquisitions, such as Dexcom's acquisition of TypeZero Technologies, which aim to enhance automated insulin delivery systems. These developments are part of a broader trend towards integrating advanced technologies to improve diabetes management. The French National Health Strategy emphasizes prompt access to medical innovations, which supports the market's expansion. However, challenges remain, including financial strains on healthcare systems and the need for substantial clinical benefits to justify the costs of new technologies. Despite these challenges, the market is expected to grow, supported by initiatives to improve patient adherence to medical recommendations and reduce complications associated with diabetes.
France Diabetes Devices Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.3 Market Restraints
-
1.4 Industry Attractiveness - Porter's Five Forces Analysis
-
1.4.1 Bargaining Power of Buyers/Consumers
-
1.4.2 Bargaining Power of Suppliers
-
1.4.3 Threat of New Entrants
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 Monitoring Devices
-
2.1.1 Self-monitoring Blood Glucose Devices
-
2.1.1.1 Glucometer Devices
-
2.1.1.2 Test Strips
-
2.1.1.3 Lancets
-
-
2.1.2 Continuous Blood Glucose Monitoring
-
2.1.2.1 Sensors
-
2.1.2.2 Durables
-
-
-
2.2 Management Devices
-
2.2.1 Insulin Pump
-
2.2.1.1 Insulin Pump Device
-
2.2.1.2 Insulin Pump Reservoir
-
2.2.1.3 Infusion Set
-
-
2.2.2 Insulin Syringes
-
2.2.3 Insulin Cartridges
-
2.2.4 Disposable Pens
-
-
France Diabetes Devices Market Size FAQs
How big is the France Diabetes Devices Market?
The France Diabetes Devices Market size is expected to reach USD 1.30 billion in 2024 and grow at a CAGR of 6.58% to reach USD 1.79 billion by 2029.
What is the current France Diabetes Devices Market size?
In 2024, the France Diabetes Devices Market size is expected to reach USD 1.30 billion.
